Abstract:Background Preoperative pathological grading assessment is important for patients with breast phyllodes tumors (PTs). Purpose To develop and validate a clinical–radiomics model based on multiparametric MRI and clinical information for the pretreatment differential diagnosis of PTs. Study Type Retrospective. Population A total of 216 patients with PTs, 133 in the training cohort (55 benign PTs [BPTs] and 78 borderline/malignant PTs [BMPTs]) and 83 in the validation cohort (28 BPTs and 55 BMPTs). Field Strength/Sequence 1.5 T and 3 T; T2‐weighted imaging (T2WI), precontrast T1‐weighted imaging (T1WI) and dynamic contrast‐enhanced T1‐weighted imaging (DCE‐T1WI). Assessment A total of 3138 radiomics features were computed to decode the imaging phenotypes of PTs. To build the classification models, the following workflow was followed: minimum–maximum scaling normalization method, recursive feature elimination based on ridge regression (Ridge‐RFE), synthetic minority oversampling technique, and support vector machine classifier. We established several models based on the statistically significant features (Ridge‐RFE selected) of each sequence to distinguish BPTs from BMPTs, including precontrast T1WI model, DCE‐T1WI phase 1 model, T1WI feature fusion model, T2WI model, T1WI + T2WI model, clinical feature model, conventional MRI characteristics model, and combined clinical–radiomics model. Statistical Tests Univariate analysis was utilized to compare variables between the BPT and BMPT groups. The receiver operating characteristic curve (ROC) analysis was used to evaluate the diagnostic performance of these models. Results In the training cohort, the clinical–radiomics model had excellent diagnostic efficiency, with an area under ROC (AUC) of 0.91 ± 0.02 (95% CI: 0.87–0.94). In the validation cohort, the AUCs were 0.79 ± 0.05 (95% CI: 0.70–0.87) for the combined model and 0.77 ± 0.05 (95% CI: 0.67–0.85) for the radiomics model. Data Conclusion Compared with conventional MRI characteristics, radiomics features extracted from multiparametric MRI are helpful for improving the accuracy of differentiating the pathological grades of PTs preoperatively. The model based on radiomics and clinical information is expected to become a potential noninvasive tool for the assessment of PTs grades. Evidence Level 4 Technical Efficacy Stage 2

The usefulness of evaluating PTEN expression for accurate grading of phyllodes tumors

The Clinical Significance of PTEN Protein Expression in Colorectal Carcinoma

Expression Profile And Clinical Significance Of Micrornas In Papillary Thyroid Carcinoma

Phosphatase and Tensin Homolog (PTEN) Expression as a Surrogate Biomarker Correlated With the Depth of Invasion in Cutaneous Malignant Melanoma

Mutations of PTEN Gene in 117 Chinese Patients with Malignant Melanoma and Their Clinical Significance

[Possibility of PTEN Expression on Predicting Pathologic Risk Factors of Endometrioid Adenocarcinoma Before Operation].

Correlation Between Quantitative Perfusion Histogram Parameters of DCE-MRI and PTEN, P-Akt and M-Tor in Different Pathological Types of Lung Cancer

The association between phosphatase and tensin homolog hypermethylation and patients with breast cancer, a meta-analysis and literature review

The cellular signaling and regulatory role of protein phosphatase in tumor diagnosis: Upstream miRNAs of PTEN

Regulation of the tumor suppressor PTEN by natural anticancer compounds

Immunohistochemistry and Next-generation Sequencing Are Complementary Tests in Identifying PTEN Abnormality in Endometrial Carcinoma Biopsies

Pretreatment Multiparametric MRI‐Based Radiomics Analysis for the Diagnosis of Breast Phyllodes Tumors

Comparison of immunohistochemistry and next-generation sequencing results in oncogenic PTEN missense mutations

Detailed DNA methylation characterisation of phyllodes tumours identifies a signature of malignancy and distinguishes phyllodes from metaplastic breast carcinoma

Prognostic Significance of PTEN, Ki-67 and CD44s Expression Patterns in Gastrointestinal Stromal Tumors

The expression of metabolism-related proteins in phyllodes tumors

Expression patterns of H3K27me3 for differentiation of breast fibroadenomas and phyllodes tumors

Predicting the pathological grade of breast phyllodes tumors: a nomogram based on clinical and magnetic resonance imaging features

[Clinicopathologic Features and Prognostic Factors of Malignant Phyllodes Tumors].

Targeted DNA Sequencing in Diagnosis of Malignant Phyllodes Tumors With Emphasis on Tumors With Keratin and p63 Expression

CD68 positive and/or CD163 positive tumor-associated macrophages and PD-L1 expression in breast phyllodes tumor